Navigation Links
Labopharm Reports Results for Third Quarter Fiscal 2009
Date:11/6/2009

------------------------------------- Net loss for the period (6,904) (6,017) (19,752) (26,013) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Net loss per share - basic and diluted (0.12) (0.11) (0.35) (0.46) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Weighted average number of common shares outstanding 57,388,302 56,824,106 57,020,122 56,821,325 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Labopharm Inc. INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended: For the nine months ended: September September September September 30, 30, 30, 30, 2009 2008 2009 2008 (thousands of Canadian (Restated) (Restated) dollars) $ $ $ $ ------------------------------------------------------------------------- OPERATING ACTIVITIES Net loss for the period (6,904) (6,017) (19,752) (26,013) Items not affecting cash: Depreciation of property, plant and equipment 396 471 1,229 1,386 Amortization of intangible assets 46 30 129 90 Amortization of premiums and discounts on marketable securities 36 6 90
'/>"/>
SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
2. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
3. Labopharm submits response to FDA for novel antidepressant
4. Labopharm Reports Results for Second Quarter Fiscal 2009
5. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
6. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
7. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
8. Labopharm amends debt facility agreement with Hercules
9. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
10. Labopharm Reports Results for First Quarter Fiscal 2009
11. Labopharm announces details for first quarter results conference call and annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2015)... (PRWEB) May 23, 2015 Dr. David Benvenuti, ... has just posted a new article to his ... As Dr Benvenuti explained in the fascinating blog, ... plugs in their earlobes. , Known as “gauging,” the technique ... hole, which Dr. Benvenuti said will eventually stretch the holes ...
(Date:5/23/2015)... On Wednesday, May 20, 2015, CareFirst BlueCross ... the target of a sophisticated cyberattack,” and that it, ... Information Technology (IT) security efforts in the wake of ... notable attack on health insurers was reported in February ... largest health insurer, revealed that they had suffered a ...
(Date:5/23/2015)... 23, 2015 Manufacturers are now required to ... (HSPF) of 8.2. Experts in the field agree that the ... , The HSPF score is what miles per gallon is ... the unit. Although the minimum HSPF score has been raised ... an HSPF score north of 12. Indeed, the regulation was ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Javon ... at the Sports Medicine and Rehabilitation Center, 557 N. ... program, Mondays, June 1-July 20, 5:30-6:30 pm. , The ... coach, and Laurie Finke, RN, BSN, who will offer ... education on nutrition, running mechanics and show selection and ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Injury lawyer Steven ... has been passed by the Maryland legislature but which has ... Maryland General Assembly passed HB 449 with overwhelming ... has not signed it into law. This bill ensures that ... is growing that demonstrates the danger of fracking to our ...
Breaking Medicine News(10 mins):Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3
... admitted to a Colorado trauma center appeared to decrease ... report in the January issue of Archives of Surgery, ... are accredited through the American College of Surgeons, according ... based on factors such as surgeon and nurse availability, ...
... with untreatable lung disease , , MONDAY, Jan. ... the lung disease idiopathic pulmonary fibrosis (IPF) have a ... IPF is untreatable, and patients usually die within five ... smokers with IPF may live longer than former smokers, ...
... The Veterinary Division of,FLAVORx, Inc., which ... the nation,s largest compounding pharmacy, have,teamed up ... veterinarians to make pet,medications taste good. The ... add flavors to specially-formulated prescription,suspensions from Wedgewood ...
... A $7,000 grant,awarded by the Delta Dental Fund ... Ohio Dental Association members to Ohio,children for the sixth ... a,children,s access to dental care event in which dentists ... This,year,s event kicks off February 1, 2008, with many ...
... HALIFAX, Jan. 21 /PRNewswire/ - ImmunoVaccine Technologies Inc. ... $3 Million from,the Atlantic Canada Opportunities Agency (ACOA), ... enable IVT to undertake a $6,million project to ... ACOA recognize the market potential of our innovative ...
... EAST AURORA, N.Y., Jan. 21 Moog Inc. (NYSE:,MOG.A ... earnings for,the period ended December 29, 2007 on Friday ... host a conference call beginning,at 10:00 a.m. EST, which ... Chairman and CEO, and John Scannell, CFO, will host,the ...
Cached Medicine News:Health News:Change in trauma level designation associated with improved patient survival 2Health News:Smoking Worsens Prognosis for IPF Patients 2Health News:FLAVORx Teams up with Wedgewood Pharmacy to Make it Even Easier to Make Pet Medications Taste Good 2Health News:FLAVORx Teams up with Wedgewood Pharmacy to Make it Even Easier to Make Pet Medications Taste Good 3Health News:Delta Dental Financial Support Helps ODA Members Serve Children in Need 2Health News:ImmunoVaccine Technologies Receives $3 Million From ACOA 2
(Date:5/22/2015)... , May 22, 2015 Electrophysiologist ... Institute recently traveled to Boston, MA ... at the 2015 Heart Rhythm Society conference. These ... to focus on the ideas, people and technology ... Convergent is a hybrid, minimally invasive cardiac operation ...
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage ... regeneration, today announced that J.J. Finkelstein , chief ... corporate overview at two upcoming investor conferences. ... th Annual Microcap Conference on Thursday May 28, ... at 11:00 am EDT.  A webcast will be available ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... a peer-reviewed publication of the results of the ... (RegeneRx,s preservative-free eye drops) for the treatment of ... environment (CAE ® ) model.  The exploratory study ... which were previously disseminated by the Company in ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4
... dual wavelength (532 nm and 940 nm) ... laser solution. This solid-state laser quickly and ... acne vulgaris. VariLite offers the clinical versatility ... as deeper, larger vessels in a convenient, ...
... PREMIUM SURGICLIP™ clip applier consists of an applier ... 15 or 20 titanium clips. , ,The ... or other tubular structure. As the handles of ... closed around the vessel or structure. As the ...
The LIGACLIP ERCA Endoscopic Rotating Multiple Clip Applier is intended for use on tubular structures or vessels wherever a metal ligating clip is indicated. The tissue being ligated should be consis...
The Tissue Approximating Forceps are to aid in the approximating of the tissue edges....
Medicine Products: